SOX9 and hepatocellular carcinoma: Overall, these data further support a critical role for SOX9 in the mechanisms underlying fibrosis and indicate the value of investigating SOX9-regulated pathways as serum biomarkers or as potential targets to reduce fibrosis and its progression to cirrhosis and HCC.